293b cpd has been researched along with Torsade de Pointes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dumotier, B; Guérard, N; Jordaan, P | 1 |
Ando, H; Asakura, K; Hayashi, S; Kanda, Y; Kasai, C; Miyamoto, N; Ojima, A; Osada, T; Sawada, K; Sekino, Y; Sugiyama, A; Taniguchi, T; Tashibu, H; Uda, T; Yamamoto, W; Yamazaki, D; Yoshinaga, T | 1 |
Aiba, T; Ding, WG; Horie, M; Inagaki, M; Matsuura, H; Miyoshi, S; Noda, T; Shimizu, W; Sunagawa, K; Toyoda, F; Zankov, DP | 1 |
Antzelevitch, C; Shimizu, W | 1 |
4 other study(ies) available for 293b cpd and Torsade de Pointes
Article | Year |
---|---|
Analysis of unipolar electrograms in rabbit heart demonstrated the key role of ventricular apicobasal dispersion in arrhythmogenicity.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Chromans; Electrophysiologic Techniques, Cardiac; Endocardium; Pericardium; Quinidine; Rabbits; Sotalol; Sulfonamides; Torsades de Pointes | 2014 |
Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.
Topics: Cells, Cultured; Chromans; Cisapride; Electrophysiological Phenomena; Heart Rate; Humans; Induced Pluripotent Stem Cells; Linear Models; Models, Cardiovascular; Myocytes, Cardiac; Piperidines; Pyridines; Sulfonamides; Torsades de Pointes | 2016 |
Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cats; Chromans; Heart; Long QT Syndrome; Piperidines; Potassium Channel Blockers; Potassium Channels; Pyridines; Sulfonamides; Tissue Culture Techniques; Torsades de Pointes; Verapamil | 2005 |
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chromans; Cnidarian Venoms; Dogs; Electrocardiography; Electrophysiology; Heart; Isoproterenol; Long QT Syndrome; Nicorandil; Potassium Channels; Reaction Time; Sotalol; Sulfonamides; Torsades de Pointes | 2000 |